{"nct_id":"NCT01999842","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2013-11-25","start_date_type":"ACTUAL","primary_completion_date":"2014-02-01","primary_completion_date_type":"ACTUAL","completion_date":"2015-01-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}